Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggestNovember 25, 2020Genitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaOncologyLung Cancer
Using telehealth to deliver palliative care to cancer patients November 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersOncology
One-month delay in cancer treatment linked to increase in mortalityNovember 6, 2020Breast CancerHead & Neck/Thyroid CancersGenitourinary CancerLung CancerOncology
Real-world results with checkpoint inhibitors found inferior to trial resultsOctober 30, 2020Lung CancerMelanomaHead & Neck/Thyroid CancersGenitourinary Cancer
PET guidance for radiation therapy improves prostate cancer outcomesOctober 29, 2020Genitourinary Cancer
Single and multifraction SBRT found comparable for lung metastasesOctober 28, 2020Genitourinary CancerLung CancerOncology
‘Tour de force’ study reveals therapeutic targets in 38% of cancer patientsOctober 27, 2020Breast CancerGenitourinary CancerLung Cancer
Lower BP and better tumor control with drug combo?October 26, 2020Lung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersMelanoma
The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Global stomach cancer deaths decline as colorectal cancer deaths stagnate, riseSeptember 25, 2020Breast CancerLung CancerGenitourinary CancerOncology
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020Breast CancerLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerMelanomaLymphoma & Plasma Cell Disorders
If PPIs are onboard, atezolizumab may not work for bladder cancerSeptember 17, 2020Genitourinary Cancer
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaOncology
